PubMed Health⌕ Search

Biomedical subjects

D J Steward

Publications and source records attributed to D J Steward.

At least 19 recordsLinked to original sources

Assessment of pediatric patients for general anesthesia: the child with an upper respiratory infection and the ex-premature infant.

There are two types of patients that commonly lead surgeons and anesthesiologists into discussions relating to the possible cancellation or postponement of a minor pediatric surgical procedure; the child with a recent upper respiratory infection, and the patient who was born prematurely. Current opinion of the risks of anesthesia in such patients and the factors that influence perioperative course are reviewed, and a plan of management is suggested.

Anesthesia, General↗

The effect of syringe size on the performance of an infusion pump.

This study investigated the effect of using three different sized syringes on the accuracy of fluid delivery when using an infusion pump at low infusion rates (1 ml.h-1). The study also measured the influence of the syringe size on the time to occlusion alarm, and on the size of the subsequent bolus dose that might be infused after relief of the occlusion which triggered the alarm. The use of a larger size syringe was found not to affect the accuracy of infusate delivery, but delayed the time to occlusion alarm and increased the size of the postocclusion bolus dose.

Equipment Design↗

Genetic association between sensitivity to warfarin and expression of CYP2C9*3.

Cytochrome P4502C9 (CYP2C9) is largely responsible for terminating the anticoagulant effect of racemic warfarin via hydroxylation of the pharmacologically more potent S-enantiomer to inactive metabolites. Mutations in the CYP2C9 gene result in the expression of three allelic variants, CYP2C9*1, CYP2C9*2 and CYP2C9*3. Both CYP2C9*2 and CYP2C9*3 exhibit altered catalytic properties in vitro relative to the wild-type enzyme. In the present study, a patient was genotyped who had proven unusually sensitive to warfarin therapy and could tolerate no more than 0.5 mg of the racemic drug/day. PCR-amplification of exons 3 and 7 of the CYP2C9 gene, followed by restriction digest or sequence analysis, showed that this individual was homozygous for CYP2C9*3. In addition, patient plasma warfarin enantiomer ratios and urinary 7-hydroxywarfarin enantiomer ratios were determined by chiral-phase high performance liquid chromotography in order to investigate whether either parameter might be of diagnostic value in place of a genotypic test. Control patients receiving 4-8 mg warfarin/day exhibited plasma S:R ratios of 0.50 +/- 0.25:1, whereas the patient on very low-dose warfarin exhibited an S:R ratio of 3.9:1. In contrast, the urinary 7-hydroxywarfarin S:R ratio of 4:1 showed the same stereoselectivity as that reported for control patients. Therefore, expression of CYP2C9*3 is associated with diminished clearance of S-warfarin and a dangerously exacerbated therapeutic response to normal doses of the racemic drug. Analysis of the plasma S:R warfarin ratio may serve as a useful alternative test to genotyping for this genetic defect.

Anticoagulants↗

Severe bronchospasm during cardiopulmonary bypass.

PURPOSE: To describe the rare problem of severe bronchospasm occurring during cardiopulmonary bypass in a six-year-old-child. CLINICAL FEATURES: Severe bronchospasm became apparent on attempting to resume controlled ventilation prior to weaning from cardiopulmonary bypass. The patient had a previous history of asthma but was asymptomatic preoperatively. Aggressive therapy with multiple bronchodilating agents was necessary before cardiopulmonary bypass could be discontinued. The bronchospasm resolved over the first 24 hr after surgery. CONCLUSION: Severe bronchospasm during cardiopulmonary bypass is rare. It should only be diagnosed after ruling out other reasons for failure to ventilate. Treatment with intravenous bronchodilators is required. The cause is unknown.

Bronchial Spasm↗

Can persistent cerebral damage be caused by hyperglycaemia?

An eight-year-old girl demonstrated severe and persistent neurological damage following an uneventful anaesthetic for a planned appendicectomy. The perioperative period was remarkable only in that the patient experienced very severe hyperglycaemia and an epileptiform convulsion. A possible mechanism for neurological damage as a result of severe hyperglycaemia is described.

Anesthesia, General↗

A multicentre randomized study of single-unit dose package of EMLA patch vs EMLA 5% cream for venepuncture in children.

Eutectic mixture of local anaesthetics (EMLA) cream with Tegaderm was compared with pre-packaged EMLA patch with regard to analgesic effect, adhesiveness and local reactions during venepuncture in 178 children from three to ten years. One EMLA patch, or half the contents of a 5 g tube of EMLA cream plus Tegaderm was applied to the dorsum of one hand or antecubital fossa for a minimum of 60 min before venepuncture. The subject and observer assessed the degree of pain on a three-point verbal rating scale. The adhesion of the patch vs Tegaderm to the skin and local reactions were recorded. There was no difference between the two groups in pain associated with venepuncture; 95% of the EMLA patch group and 94% of the EMLA cream group reported no or slight pain. There was no difference between the two treatment groups in terms of overall local reactions. The patch was less adhesive (P < 0.001), but this had no apparent influence on its effectiveness. In conclusion, EMLA patch is equivalent to 5% EMLA cream (2.5 g) in cutaneous pain relief when used for venepuncture in children.

Adhesiveness↗

Postoperative analgesia: opioid infusions in infants and children.

The purpose of this review is to emphasise the ineffectiveness of traditional analgesic therapy in paediatric patients after surgery, to examine the sensation of pain in infants and children, and to describe the use of intravenous opioids for postoperative analgesia. The management of acute postoperative pain in the paediatric surgical population has been poor. This is despite the knowledge that infants and children have sufficient neurological development at birth to sense pain, and that the same hormonal and metabolic responses to nociceptive stimuli that occur in adult also occur in the neonate. Physicians frequently order analgesics in inappropriate doses, nurses are reluctant to administer opioids, and children themselves frequently compound the problem by refusing injections. The sophisticated techniques for providing postoperative analgesia which have been used so successfully in adults can also be used in paediatric patients. Two of these, continuous intravenous opioid infusion and patient-controlled analgesia, have proved to be very successful. Children older than six months can receive either modality safely with regular monitoring by qualified nursing staff. Infants younger than six months receiving continuous opioid infusions should be monitored in high-dependency units.

Analgesia, Patient-Controlled↗

The accuracy and variability of bolus injections with different sized syringes.

The accuracy of bolus injections using different sized syringes was studied. A 1 ml bolus was delivered from a 1 ml, 5 ml, 10 ml, and a 20 ml syringe (n = 205). The 1 ml syringe was the most accurate (P less than 0.001) and the bolus delivered was the least variable (P less than 0.001). Variability increased as syringe size increased. A 3 ml bolus was delivered from a 3 ml, 5 ml, 10 ml, and a 20 ml syringe (n = 164). The 5 ml syringe was the most accurate (P less than 0.05) and the 3 ml and 5 ml syringes delivered a bolus with the least variability (P less than 0.001). A 5 ml bolus was delivered from a 5 ml, 10 ml, and a 20 ml syringe (n = 123); in this case there was no significant difference in the accuracy or variability of bolus among the three syringes. We conclude that for accuracy of small volume boluses (less than 5 ml), small-sized syringes should be used.

Analysis of Variance↗

Myocardial oedema and ventricular function after cardioplegia with added mannitol.

Myocardial oedema may contribute to the impaired myocardial performance which commonly follows open heart surgery with cardioplegia-induced cardiac arrest. The rate of oedema formation during crystalloid cardioplegia and the relation of this to changes in ventricular compliance and ventricular function following reperfusion were studied using an isolated rabbit heart preparation. Myocardial tissue water content increased during cardioplegic arrest and the water content prior to reperfusion demonstrated an inverse correlation with ventricular function after reperfusion. In further studies the effect of adding mannitol to a standard crystalloid cardioplegic solution was investigated. The preparations were divided into two groups: nine were administered a standard cardioplegic solution (Plegisol*) (control group) and a further eight were administered the same solution mixed with mannitol to adjust the osmotic pressure to 360 mOsmol.L-3 (mannitol group). The mannitol group demonstrated less increase in RV water content and superior LV dP/dtmax following reperfusion. It is concluded that mannitol enhances protection of the myocardium during cardioplegic cardiac arrest.

Animals↗